Adage Capital Partners’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,000,000
| Closed | -$5.81M | – | 725 |
|
|
2019
Q4 | $5.81M | Sell |
1,000,000
-418,822
| -30% | -$2.43M | 0.01% | 594 |
|
|
2019
Q3 | $7.48M | Buy |
1,418,822
+250,000
| +21% | +$1.32M | 0.02% | 577 |
|
|
2019
Q2 | $7.01M | Buy |
1,168,822
+50,000
| +4% | +$300K | 0.02% | 573 |
|
|
2019
Q1 | $10.1M | Buy |
1,118,822
+573,822
| +105% | +$5.18M | 0.03% | 525 |
|
|
2018
Q4 | $4.52M | Buy |
545,000
+154,000
| +39% | +$1.28M | 0.01% | 613 |
|
|
2018
Q3 | $5.4M | Sell |
391,000
-359,000
| -48% | -$4.95M | 0.01% | 632 |
|
|
2018
Q2 | $5.96M | Hold |
750,000
| – | – | 0.01% | 638 |
|
|
2018
Q1 | $5.63M | Buy |
750,000
+57,000
| +8% | +$428K | 0.01% | 634 |
|
|
2017
Q4 | $4.71M | Sell |
693,000
-57,000
| -8% | -$388K | 0.01% | 630 |
|
|
2017
Q3 | $5.4M | Buy |
750,000
+275,000
| +58% | +$1.98M | 0.01% | 619 |
|
|
2017
Q2 | $2.21M | Hold |
475,000
| – | – | 0.01% | 661 |
|
|
2017
Q1 | $2.38M | Buy |
+475,000
| New | +$2.38M | 0.01% | 657 |
|